Sharemaestro Newsreel

LifeStance Health Group (NASDAQ:LFST) Reports Strong Q2 CY2026, Guides for Strong Full-Year Sales

LifeStance Health Group (NASDAQ:LFST) reported strong Q2 CY2026 results, surpassing Wall Street's revenue and EPS expectations. The company's sales rose 26.1% year-on-year to $435.4 million, and its GAAP profit was $0.06 per share. LifeStance also raised its full-year revenue and EBITDA guidance, indicating a …

LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook

LifeStance Health Group, Inc. announced strong financial results for the second quarter of 2026, with revenue increasing by 26% to $435.4 million and net income reaching $23.6 million. The company raised its full-year 2026 outlook for revenue, Center Margin, and Adjusted EBITDA, and approved …

Brookdale Senior Living spends $157 million to buy 17 communities it currently leases, manages

Brookdale Senior Living is acquiring 17 communities it currently leases and manages for approximately $157 million, increasing its real estate ownership to 77% of its portfolio. This move is expected to reduce long-term lease obligations, improve adjusted EBITDA and cash flow, and give Brookdale …

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Receives Average Rating of "Reduce" from Brokerages

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) has received an average rating of "Reduce" from eleven brokerage firms, with five recommending a sell and six a hold. The average 12-month price target is $22.45, below its opening price of $23.91. Despite the "Reduce" …

First Trust Advisors LP Purchases Shares of 93,677 Guardian Pharmacy Services, Inc. $GRDN

Pennant Group, Inc. 2026: Revenue $297.98M, EPS $0.25— 10-Q Summary

Pennant Group, Inc. reported strong financial results for the quarter ended 2026, with consolidated revenue reaching $297.98M, marking a 35.8% increase year-over-year, and diluted EPS rising to $0.25. The growth was primarily driven by a significant increase in home health & hospice revenue and …

WW International Q2 Earnings Call Highlights

WW International (Weight Watchers) reported Q2 2026 revenue of $162.3 million, down from the previous year, but highlighted growth in its clinical and higher-value behavioral membership tiers. The company reaffirmed its full-year financial outlook and saw its clinical subscribers reach 197,000, a 55.7% increase …

PACS Group (PACS) Stock Climbs As Margins Strengthen And Risks Linger

PACS Group (PACS) stock climbed 1.9% after reporting strong Q2 2026 earnings, with net income up 50% and net margin improving to 4.8%. While the company shows solid operational progress and margin expansion, investors are weighing this against a P/E of 26.8x, ongoing legal …

AMN Healthcare search revenue grew 27% after Q2 results exceeded guidance

LifeStance Health Group (LFST) Earnings Date and Reports 2026 $LFST

Aveanna Healthcare (AVAH) Expected to Announce Earnings on Thursday

AMN Healthcare Services (AMN) Earnings Date and Reports 2026

The Joint Corp. (JYNT) Reports Q2 Loss, Tops Revenue Estimates

Oncology Institute (NASDAQ:TOI) Issues Quarterly Earnings Results, Misses Estimates By $0.01 EPS

Can Strata Critical Medical, Inc. (SRTA) Run Higher on Rising Earnings Estimates?

[10-Q] Concentra Group Holdings Parent, Inc. Quarterly Earnings Report

Concentra Group Holdings Parent Inc (CON) is scheduled to release its Q2

Pennant Group (PNTG) Stock Faces Margin Scrutiny Behind Stronger Revenue

B. Riley Financial Forecasts Strong Price Appreciation for Compass Pathways (NASDAQ:CMPS) Stock

Truist Financial Issues Positive Forecast for PACS Group (NYSE:PACS) Stock Price

Astrana Health, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:ASTH) 2026-08-06

Encompass Health (NYSE:EHC) Shares Gap Up After Earnings Beat

Nutex Health (NASDAQ:NUTX) Releases Earnings Results, Beats Expectations By $4.63 EPS

AGILON HEALTH, INC. : JEFFERIES RAISES TARGET PRICE TO $135 FROM $115

Jefferies has increased its target price for Agilon Health, Inc. from $115 to $135. This update was reported by Reuters on August 6, 2026. The article also briefly mentions other analyst target price changes and cryptocurrency prices.

PACS renews M&A push, raises guidance as occupancy clears 90%

PACS Group is aggressively re-entering the acquisition market, buoyed by strong occupancy rates exceeding 90% and improved labor conditions. The company raised its full-year 2026 revenue guidance to $5.75 billion to $5.85 billion and adjusted EBITDA guidance to $640 million to $660 million after …

Earnings Flash (AMN) AMN Healthcare Services, Inc. Posts Q2 Adjusted EPS $0.77 per Share, vs. FactSet Est of $0.19

AMN Healthcare Services, Inc. (AMN) announced its Q2 adjusted EPS of $0.77 per share, significantly surpassing the FactSet estimate of $0.19. The company also reported Q2 revenue of $673.2 million, exceeding the FactSet estimate of $628.4 million, and provided Q3 revenue guidance ranging from …

Healthcare Services Group, Inc. (HCSG) Stock Price, News, Quote & History

This article provides a comprehensive overview of Healthcare Services Group, Inc. (HCSG) stock performance, financial data, and company information. It includes real-time stock price, historical data, key financial metrics, analyst insights, and comparisons with similar companies. The company specializes in providing management and operational …

U.S. Physical Therapy (USPH) Posted Mixed Q2 Results, Is The Stock Still Undervalued?

U.S. Physical Therapy (USPH) reported mixed Q2 2026 results with increased revenue but lower net income and EPS, alongside affirming a $0.46 quarterly dividend. Despite a recent 31.71% share price surge over 90 days, the stock's year-to-date performance is slightly down, and its 3-year …

Compass Pathways (Nasdaq: CMPS) grows cash to $433M as COMP360 trials succeed

Compass Pathways plc reported a net loss of $162.6 million for the first six months of 2026, largely due to non-cash warrant liabilities and increased administrative spending, yet saw its cash and cash equivalents grow to $433.3 million. This financial boost was driven by …

Ardent Health (ARDT) Stock Climbs Even As Margins Tighten Sharply

Compared to Estimates, Encompass Health (EHC) Q2 Earnings: A Look at Key Metrics

Encompass Health (EHC) reported Q2 2026 revenue of $1.6 billion, a 9.6% increase year-over-year, and an EPS of $1.55, up from $1.40. Both figures surpassed analyst estimates, with revenue showing a 1.52% surprise and EPS a 4.73% surprise. Key metrics like net patient revenue …

Strata Critical Medical Reports Q2 2026 Results: Full Earnings Call Transcript

Strata Critical Medical reported strong Q2 2026 results with significant sequential growth in clinical revenue and increased clinical gross margins, driven by strategic acquisitions. The company raised its 2026 revenue and adjusted EBITDA guidance, reflecting accelerated clinical growth and M&A, despite short-term logistics margin …

Addus HomeCare Q2 Momentum Seen Continuing, RBC Says

RBC Capital Markets believes Addus HomeCare (ADUS) will continue its strong Q2 momentum into the second half of 2026, driven by improved staffing, acquisition benefits, and higher reimbursement rates. The firm expects ADUS to achieve double-digit organic growth and views it as a top …

National Healthcare Properties Q2 FY26 net loss narrows to $8.14 million; revenue rises 2.58% to $87.53 million

National Healthcare Properties reported a narrowed GAAP net loss of $8.14 million in Q2 FY26, with revenue increasing by 2.58% to $87.53 million. Nareit-defined FFO remained flat, while normalized FFO decreased. The company saw improvements in SHOP same-store cash NOI and occupancy, closed 19 …

Akebia Therapeutics Q2 Earnings Call Highlights

Akebia Therapeutics (NASDAQ: AKBA) reported its Q2 2026 earnings, highlighting a significant 60% year-over-year increase in Vafseo revenue to $21.3 million, driven by over 10,500 active patients. The company also announced that its VOICE trial for Vafseo met its interim stopping criteria, demonstrating a …

AMN Healthcare Services (AMN) Q2 Earnings Report Preview: What To Look For

AMN Healthcare Services (NYSE:AMN) is set to release its Q2 earnings report this Thursday after market close. Analysts anticipate a 4.5% year-on-year revenue decline, an improvement from the 11.1% decrease in the same quarter last year. The company has a history of exceeding Wall …

WW International, Inc. (NASDAQ:WW) Looks Inexpensive After Falling 30% But Perhaps Not Attractive Enough

WW International (NASDAQ:WW) shares have dropped 30% in the last month, contributing to a 73% loss over the past year, making its 0.1x Price-to-Sales (P/S) ratio seem inexpensive compared to the industry average of 1.6x. However, the company's revenue has been declining, with an …